Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genital Tuberculosis, Latent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableStudy completedNCT00947609
What this trial is testing

Improving Latent Tuberculosis (TB) Diagnosis in Thai Children

Who this might be right for
Latent TuberculosisHIV Infections
SEARCH Research Foundation 158
Not applicableStudy completedNCT05268380
What this trial is testing

Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia

Who this might be right for
COVID-19HIV SeropositivityTuberculosis, Pulmonary+1 more
University of Namibia 1,750
Testing effectiveness (Phase 2)Active Not RecruitingNCT05122026
What this trial is testing

Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV

Who this might be right for
HIV SeropositivityPregnancyTuberculosis Infection
The Aurum Institute NPC 252
Early research (Phase 1)Not Yet RecruitingNCT07600775
What this trial is testing

A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC 14
Not applicableLooking for participantsNCT04700579
What this trial is testing

Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis

Who this might be right for
TB - TuberculosisHIV/AIDS
University of Stellenbosch 150
Large-scale testing (Phase 3)Ended earlyNCT00080119
What this trial is testing

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

Who this might be right for
HIV InfectionTuberculosisPneumocystis Jiroveci Pneumonia
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1,354
Not applicableUnknownNCT05685641
What this trial is testing

Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City

Who this might be right for
Acquired Immunodeficiency SyndromeHistoplasmosis AIDSTuberculosis Infection+1 more
National Institute of Respiratory Diseases, Mexico 211
Not applicableNot Yet RecruitingNCT07737275
What this trial is testing

Screening With Portable X-rays for Rapid Recognition of TB

Who this might be right for
Tuberculosis (TB)Tuberculosis Infection, LatentHIV (Human Immunodeficiency Virus)
Columbia University 1,000
Testing effectiveness (Phase 2)Study completedNCT03435146
What this trial is testing

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)

Who this might be right for
Respiratory Tract InfectionsHIV Infections
The Aurum Institute NPC 135
Not applicableStudy completedNCT04545164
What this trial is testing

Computer Aided Screening for Tuberculosis in Low Resource Environments

Who this might be right for
Tuberculosis InfectionHIV Infections
London School of Hygiene and Tropical Medicine 498
Not applicableStudy completedNCT00000636
What this trial is testing

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 2,000